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a b s t r a c t
Fatty acid-binding protein 3 (Fabp3) is an intracellular lipid trafﬁcking protein that mediates energy
metabolism and long-chain fatty acid-related signaling. Fabp3 is expressed in the spiral ganglion neurons
and supporting cells of the organ of Corti. However, it is unclear what role Fabp3 plays in the cochlea.
Here, we demonstrated that the ABR thresholds of young and aged Fabp3 knockoutmicewere unchanged
compared with those of wild-type mice. Compared with the wild-type mice, the adult mutant mice
demonstrated no differences in their vulnerability to acoustic overexposure. These results suggest thateywords:
atty acid-binding protein 3 (Fabp3)
-Fabp
ochlea
coustic overexposure
Fabp3 deﬁciency alone does not adversely affect hearing function.
© 2014 The Authors. Published by Elsevier Ireland Ltd and the Japan Neuroscience Society.
Open access under CC BY-NC-ND license.ge-related hearing loss (AHL)
oise-induced hearing loss (NIHL)
. Rapid communication
Fatty acid-binding proteins (Fabps) are intracellular lipid traf-
cking proteins that bind to fatty acids (FAs) and other lipophilic
ubstances and regulate metabolic pathways. Fabps also modu-
ate gene expressions (Furuhashi and Hotamisligil, 2008; Owada,
008; Storch and Thumser, 2010). The Fabp family has at least
0 members in mammals (Liu et al., 2008); two members, Fabp3
heart-type, H-Fabp) and Fabp7 (brain-type, B-Fabp), have been
dentiﬁed in the mouse cochlea (Saino-Saito et al., 2010).
Fabp3 is required for long-chain FA transport to maintain
fﬁcient mitochondrial beta-oxidation, and it interacts with the
uclear receptors (e.g., PPAR-alpha) in the heart (Tan et al.,
002; Storch and Thumser, 2010). Fabp3 knockout (KO) mice
xhibit major alterations in peripheral free long-chain FA utiliza-
ion, acute exercise intolerance in young age groups, and cardiac
ypertrophy in old age groups (Binas et al., 1999). Fabp3 is also
xpressed in the adult brain, and it is necessary to maintain the
-6/n-3-polyunsaturated fatty acid (PUFA) balance, particularly
or arachidonic acid (ARA) uptake and metabolism in neurons
∗ Corresponding author. Tel.: +81 022 717 8203; fax: +81 022 717 8205.
E-mail addresses: norikoosumi1128@gmail.com, osumi@med.tohoku.ac.jp
N. Osumi).
ttp://dx.doi.org/10.1016/j.neures.2014.02.003
168-0102 © 2014 The Authors. Published by Elsevier Ireland Ltd and the Japan Neur(Murphy et al., 2005; Storch and Thumser, 2010). An imbalance
in the n-6/n-3-PUFA ratio may be a pathological factor in several
neuropsychiatric disorders (Sakayori and Osumi, 2013). FABP3 lev-
els are decreased in the brains of patients with Down syndrome
and Alzheimer’s disease (Cheon et al., 2003), which provides indi-
rect evidence of a relationship between FABP3 and neurological
functions and diseases (Storch and Thumser, 2010). These stud-
ies indicate that Fabp3 may have an important role in maintaining
normal brain functions.
The cochlea is amainpathological region for sensorineural hear-
ing loss (e.g., age-related hearing loss [AHL] and noise-induced
hearing loss [NIHL]) (Ohlemiller, 2008; Kidd Iii and Bao, 2012).
There are no effective treatments for sensorineural hearing loss;
therefore, it is important to recognize the molecular mechanisms
at work in the cochlea. Fabp3 is expressed in supporting cells (e.g.,
the inner and outer pillar cells and outer phalangeal cells) in the
organ of Corti (OC) and spiral ganglion (SG) neurons (Saino-Saito
et al., 2010), which suggests its role in regulating the hearing func-
tion. However, no studies of the Fabp3 function in the cochlea have
been reported. Fabp3 is involved in apoptosis (Zhu et al., 2011;
Song et al., 2012), which is critical in various pathophysiologi-
cal processes. Apoptosis is also critical for AHL (Yamasoba et al.,
2013) and NIHL (Op de Beeck et al., 2011). Therefore, we evalu-
ated the cochlear function of Fabp3 KO mice and focused on AHL
and NIHL.
oscience Society. Open access under CC BY-NC-ND license.
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Table 1A
A list of antibodies used in this study.
Antibodies and dye Dilution Suppliers Note
Anti-Fabp3 1:50 Hycult Biotechnology, HM2016 Mouse monoclonal IgG1
Anti-Fabp7 1:1000 A gift from Dr. Owada Rabbit polyclonal Igs
Anti-Sox2 1:500 R&D systems, AF2018 Goat polyclonal Igs
Anti-Myosin 7a 1:500 Abcam, ab3481, Rabbit polyclonal Igs
Alexa Fluor 488 Donkey Anti-Mouse IgG (H+L) 1:400 Invitrogen, A-21202 For anti-Fabp3
Alexa Fluor 488 Donkey Anti-Goat IgG (H+L) 1:400 Invitrogen, A-11055 For anti-Sox2
Cy3 DonkeyAnti-Mouse IgG (H+L) 1:400 Jackson ImmunoResearch, 715-165-150 For anti-Fabp3
Cy3 DonkeyAnti-Rabbit IgG (H+L) 1:400 Jackson ImmunoResearch, 711-165-152 For anti-Fabp7
DyLight 649 Donkey Anti-Rabbit IgG (H+L) 1:500 Jackson ImmunoResearch, 711-495-152 For anti-Myosin 7a
Biotin.SP. Donkey Anti-Mouse IgG (H+L) 1:1000 Jackson ImmunoResearch, 715-065-150 For anti-Fabp3
Table 1B
A list of primers used in this study.
Gene Name Reference sequence Forward primer (5′–3′) Reverse primer (5′–3′) Product size (bps)
Fabp3 NM 010174.1 GAA TAG AGT TCG ACG AGG TGA CCT CCT TCT CAT AAG TCC GAG T 195
Fabp7 NM 021272 TGG ATG GAG ACA AGC TCA TTC AAC AGC GAA CAG CAA CGA TA 126
Fig. 1. Fabp3 expression in the cochlea of an adult mouse (age 3–4 months). (A and A′′) Fabp3 and Fabp7 expression patterns in the organ of Corti (OC) and the spiral limbus
(SLim). Fabp3 is localized only in the OC (A and A′′). (B and B′′) Fabp3 and Fabp7 expression patterns in the spiral ganglion (SG). Fabp3 is detected in the SG neurons (B
and B′′), and Fabp7 is detected in the satellite cells (B′ and B′′). (C and C′′′) Confocal images of the OC. Fabp3 is localized in the nuclei and cytoplasms of Sox2-positive and
Myo7a-negative supporting cells: Deiters cells (DCs) and inner and outer pillar cells (PCs) (C and C′′′). A summary of the Fabp3 expression is shown in (D). Abbreviations:
inner hair cell (IHC) and outer hair cells (OHCs). Scale bars represent (A′′ and B′′) 100m and (C′′′) 20m.
66 J. Suzuki et al. / Neuroscience Research 81–82 (2014) 64–68
Fig. 2. Fabp7 mRNA expression is unchanged in the Fabp3 knockout mice. (A–F) Low-magniﬁcation images (A and D) and high-magniﬁcation images (B, C, E and F) of
Fabp3(+/+) mice (A–C) and Fabp3(−/−) mice (D–F) using DAB staining. Despite apparent background signals in the bone, strong Fabp3 expression is observed in the spiral
ganglion (SG) neurons (A and B) and supporting cells in the organ of Corti (OC) (A and C) of Fabp3(+/+) mice. In contrast, Fabp3 expression is absent in Fabp3(−/−) mice
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sD–F). (G) Fabp3 and Fabp7 mRNA levels in the cochleae of Fabp3(+/+) and Fabp3(−
xpression is unchanged in Fabp3(+/+) and Fabp3(−/−) mice. Abbreviations: spiral l
00m.
We used Fabp3 KO (Fabp3(−/−)) (Binas et al., 1999) and wild-
ype (Fabp3(+/+)) mice with a C57BL/6 genetic background. The
ollowing primers were used for genotyping: Fabp3 wild-type for-
ard 5′-agc cga gtg gac agg ctc aag g-3′, Fabp3 KO forward 5′-taa
gc gca tgc tcc aga ctg cc-3′, and Fabp3 common reverse 5′-caa ggc
ac cag cag gtc aca g-3′. The Ethics Committee for Animal Experi-
ents of TohokuUniversity Graduate School ofMedicine approved
ll experimental procedures (no. 2011-231).
We conﬁrmed the Fabp3 expression patterns in the cochlea
f female wild-type mice (age 3–4 months). The mice were
nesthetized using diethyl ether and perfused with 0.01M
hosphate-buffered saline (PBS) and 4% paraformaldehyde (PFA)
n PBS (pH 7.4). The inner ears were post-ﬁxed with 4% PFA
t 4 ◦C overnight, decalciﬁed in 10% ethylenediaminetetraacetic
cid (EDTA) for 2 days at 4 ◦C, sequentially treated in 10% and
0% sucrose, embedded in Tissue-Tek O.T.C. Compound (Sakura
inetechnical), and frozen on dry ice. Thin sections (10m) were
ut using a cryostat (CM3050, Leica Instruments). Immunohisto-
hemistry was performed with modiﬁcation (Suzuki et al., 2013)
ccording to a previously described procedure. Brieﬂy, tissue sec-
ions were rinsed in 0.1% Triton X-100/Tris buffered saline (TBS),
locked with 3% bovine serum albumin/0.3% Triton X-100/TBS for
0min at room temperature, and incubated with an unconjugated
fﬁniPure Fab fragment Anti-Mouse IgG (1:10, Jackson ImmunoRe-
earch) for 2h at room temperature. The primary and secondaryice. Fabp3 mRNA expression is undetectable in Fabp3(−/−) mice, and Fabp7 mRNA
(SLim) and spiral ligament (SLim). Scale bars represent (A) 200m and (B and C)
antibodies are listed in Table 1A. The sections were incubated
overnightwithprimary antibodies at 4 ◦C followedby the appropri-
ate secondary antibodies for 1 hr at room temperature. The samples
were visualized enzymatically using the avidin-biotin complex
(VECTASTAINEliteABCKit, Vector Labs) and3,3′-diaminobenzidine
(DAB). The nuclei were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI) (1:2000) using ﬂuorescent immunochemistry.
Fluorescence images and light imageswere obtainedusing amicro-
scope (BZ-9000, Keyence) and BZ-H1C software (Keyence) or a
laser-scanning confocalmicroscope (LSM510-Meta, Zeiss) andLSM
Image Browser (Zeiss).
Next, we investigated the Fabp7 mRNA expression in the
cochleae of Fabp3 KO mice using quantitative real-time poly-
merase chain reaction (qRT-PCR). Male Fabp3(+/+) and Fabp3(−/−)
mice were sacriﬁced at 2 months of age, and their cochleae were
dissected. Using an RNA isolation reagent (TRIzol, Life Technolo-
gies), total RNA was isolated from 2 cochleae for each sample.
cDNA was synthesized using the SuperScript III First-Strand Syn-
thesis System (Invitrogen). Measurements were obtained using
PCR thermal cyclers (Mastercycler ep realplex, Eppendorf) and
a FastStart SYBR Green Master (Roche). The following cycling
conditions were used: 94 ◦C for 10min, 45 cycles of 94 ◦C for 10 s,
60 ◦C for 5 s, and 72 ◦C for 10 s. The samples were run in duplicate,
and the gene expression levels were determined using the Pfafﬂ
method (Pfafﬂ, 2001) with TATA box-binding protein (TBP) as
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Fig. 3. Fabp3 deﬁciency does not affect AHL progression and noise vulnerability. (A and B) Auditory brainstem response (ABR) hearing thresholds were measured at 4, 8, 12,
16, and 32kHz in both the female Fabp3(+/+) and Fabp3(−/−) mice at both 2 months (A) and 12 months of age (B). No signiﬁcant differences in ABR thresholds are observed
between the two groups. (C) Representative ABR waves at 12kHz at 12 months of age. (D) A summary of the acoustic overexposure experiments. (E and F) ABR hearing
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eletion does not affect vulnerability to severe acoustic injury. Data are expressed
sing the two-sample t-test, and p<0.05 was considered to be statistically signiﬁca
n internal standard. Signal fold-changes were determined using
ormalized data from Fabp3(+/+) mice as the controls. The primers
sed in this study are listed in Table 1B.
Fabp3 immunoreactivity was detected equally within the sup-
orting cells in the OC (Fig. 1A and A′′) and SG neurons (Fig. 1B
nd B′′) in every turn of the cochlea. Background signals, especially
n the bone, were apparent despite Fab blocking (Fig. 1B and B′′).
n contrast, Fabp7 was observed in ﬁbrocytes in the spiral lim-
us (SLim), supporting cells in the OC (Fig. 1A′ and A′′), satellite
ells in the SG (Fig. 1B′ and B′′), and ﬁbrocytes the spiral ligament
SLig, data not shown). We performed multiple immunostaining
echniques using anti-Fabp3, anti-Sox2 (a marker for supporting
ells), and anti-Myosin 7a (Myo7a, a marker for hair cells) anti-
odies to observe the detailed expression patterns of Fabp3 in
he OC. Fabp3 expression was strongly observed in the nucleus
nd weakly observed in the cytoplasm of the Sox2-positive and
yo7a-negative supporting cells (Fig. 1C and C′′′). The positional
elationship between Fabp3-positive cells andMyo7a-positive hair
ells determined that Deiters cells (DCs) and inner and outer pillar
ells (PCs) expressed Fabp3. We also investigated the absence of7 days after exposure to octave band noise (4–8kHz) for 2h at 103dB SPL (F). Fabp3
mean± the standard error of the mean (SEM). Statistical analysis was performed
Fabp3 localization in the cochleae of Fabp3(−/−) mice. Background
signals remained strong in the bone, but Fabp3 immunoreactiv-
ity was undetectable in SG neurons (Fig. 2B and E) and supporting
cells in the OC (Fig. 2C and F). qRT-PCR analysis revealed that
Fabp3 mRNA expression was undetectable in the Fabp3(−/−) mice,
and Fabp7 mRNA expression was similar in the Fabp3(+/+) and
Fabp3(−/−) mice (Fig. 2G). These results conﬁrmed the speciﬁc
expression of Fabp3 in mouse cochlea, as previously reported
(Saino-Saito et al., 2010), and indicated that the Fabp3(−/−) mice
lack Fabp3 mRNA and protein expression in the cochlea. No com-
pensatory up-regulation of Fabp7 mRNA was observed in the
cochleae of the Fabp3(−/−) mice.
The C57BL/6 strain exhibits an early progression of AHL (Zheng
et al., 1999). The effects of Fabp3 deﬁciency on AHL progression
were investigated by measuring ABR. The mice were anes-
thetized usingintraperitoneal ketamine (100mg/kg) and xylazine
(20mg/kg). ABR recordings were performed using a TDT System
3 auditory-evoked potential workstation and BioSigRP software
(Tucker-Davis Technologies). ABR responses were evoked using
tone bursts of pure tones at frequencies of 4, 8, 12, 16, and 32kHz.
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voked responses were averaged across 500 sweeps. Responses
ere collected for stimulus levels in 5-dB steps from 100dB SPL
sound pressure level) to 10dB SPL. The ABR threshold was deﬁned
s the lowest stimulus level required to produce a visual detection
f at least one ABR wave.
We measured the ABR thresholds of female Fabp3(+/+) and
abp3(−/−) mice at 2 and 12 months of age (Fig. 3A and B). ABR
hresholds of Fabp3(+/+) and Fabp3(−/−) mice showed no signiﬁ-
ant differences at 2months (Fig. 3A) and12months of age (Fig. 3B).
epresentative results from the ABR waves at 12kHz in the 12-
onth-oldmiceare shown inFig. 3C. Fabp3deﬁciencydidnot affect
he AHL progression, contrary to our expectations.
Finally,weperformedacoustic overexposure to induce aperma-
ent threshold shift (PTS) (Yoshida et al., 1999). At 2months of age,
ale Fabp3(+/+) and Fabp3(−/−)micewere exposed to an octave of
and noise (4–8kHz) at 103dB SPL for 2h. A summary of the exper-
ments is shown in Fig. 3D. The baseline ABR thresholds were not
ifferent between the Fabp3(+/+) and Fabp3(−/−) mice (Fig. 3E).
TSs were measured 7 days after the acoustic overexposure, and
o signiﬁcant differences were observed between the Fabp3(+/+)
nd Fabp3(−/−) mice (Fig. 3F). Fabp3 deﬁciency did not impact the
oise-induced PTS.
This study demonstrated that ABR thresholds in young and old
icewereunaltered in Fabp3(−/−)mice comparedwith Fabp3(+/+)
ice. We cannot exclude the possibility that the onset time of AHL
ay be different; however, our results suggest that Fabp3(−/−)
ice have normal sensory and neural functions in the cochlea.
abp3(−/−) mice showed no signiﬁcant vulnerability to the acous-
ic overexposure that causes PTS. Therefore, Fabp3 is speciﬁcally
xpressed in SG neurons, DCs, and inner and outer PCs (i.e., the
ajor cell types in hearing function), but its deﬁciency alone does
ot affect cochlear function or the protectivemechanisms of severe
coustic overexposure.
The absence of auditory dysfunction in Fabp3 KO mice may be
aused by the compensatory up-regulation of other Fabps in the
ochlea, which is similar to the dramatically increased expression
f Fabp5 in the adipocytes of Fabp4-deﬁcient mice (Hotamisligil
t al., 1996). The expression of the selected Fabps (e.g., Fabps1-5
nd Fabp7) was examined in wild-type cochlea (Saino-Saito et al.,
010). Other Fabps may co-localize in Fabp3-expressing cells and
ompensate for the lack of Fabp3. Further investigation of the other
abps in the cochlea is needed.
Fabp3 interacts with dopamine D2 receptor (D2R) in choliner-
ic interneurons andglutamatergic terminals in thedorsal striatum
f the brain, and Fabp3 KO mice exhibit D2R dysfunction and aber-
ant activation of cholinergic and glutamatergic neurotransmission
Shioda et al., 2010). D2Rs in the cochlea are localized in cochlear
erve ﬁbers and the inner spiral bundle region, and the vulner-
bility to acoustic injury that causes a temporary threshold shift
TTS) increases in mice that lack D2Rs (Maison et al., 2012). This
tudy used a PTS model to observe the effect of Fabp3 deﬁciency.
e found that the speciﬁc expression of Fabp3 in cochlear neu-
ons exhibited a less than expected impact on the vulnerability
o the severe acoustic overexposure that induces the apoptosis
f cochlear cells. However, Fabp3(−/−) mice may be vulnerable
o mild acoustic overexposure. Future studies should investi-
ate how D2R dysfunction impacts the cochlea and how it alters
he vulnerability to mild acoustic overexposure in Fabp3(−/−)
ice.
In conclusion, Fabp3 KOmice exhibited no auditory phenotypesfter aging or acoustic overexposure. Interestingly, a preliminary
elay of AHL progression was observed in mice lacking Fabp7
hich was speciﬁcally expressed in the glia and supporting cells
n the cochlea but not in the SG neurons or hair cells (Suzukiearch 81–82 (2014) 64–68
et al., unpublished). Therefore, evaluations of Fabp7 function in
the cochlea would aid in the elucidation of AHL pathophysiology.
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